Literature DB >> 12850311

A Bayesian neural network approach for modelling censored data with an application to prognosis after surgery for breast cancer.

P J G Lisboa1, H Wong, P Harris, R Swindell.   

Abstract

A Bayesian framework is introduced to carry out Automatic Relevance Determination (ARD) in feedforward neural networks to model censored data. A procedure to identify and interpret the prognostic group allocation is also described. These methodologies are applied to 1616 records routinely collected at Christie Hospital, in a monthly cohort study with 5-year follow-up. Two cohort studies are presented, for low- and high-risk patients allocated by standard clinical staging. The results of contrasting the Partial Logistic Artificial Neural Network (PLANN)-ARD model with the proportional hazards model are that the two are consistent, but the neural network may be more specific in the allocation of patients into prognostic groups. With automatic model selection, the regularised neural network is more conservative than the default stepwise forward selection procedure implemented by SPSS with the Akaike Information Criterion.

Entities:  

Mesh:

Year:  2003        PMID: 12850311     DOI: 10.1016/s0933-3657(03)00033-2

Source DB:  PubMed          Journal:  Artif Intell Med        ISSN: 0933-3657            Impact factor:   5.326


  20 in total

1.  An artificial neural network improves prediction of observed survival in patients with laryngeal squamous carcinoma.

Authors:  Andrew S Jones; Azzam G F Taktak; Timothy R Helliwell; John E Fenton; Martin A Birchall; David J Husband; Anthony C Fisher
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-05       Impact factor: 2.503

Review 2.  Clinical decision support systems for brain tumor characterization using advanced magnetic resonance imaging techniques.

Authors:  Evangelia Tsolaki; Evanthia Kousi; Patricia Svolos; Efthychia Kapsalaki; Kyriaki Theodorou; Constastine Kappas; Ioannis Tsougos
Journal:  World J Radiol       Date:  2014-04-28

Review 3.  A Tutorial on Evaluating the Time-Varying Discrimination Accuracy of Survival Models Used in Dynamic Decision Making.

Authors:  Aasthaa Bansal; Patrick J Heagerty
Journal:  Med Decis Making       Date:  2018-10-14       Impact factor: 2.583

4.  Variational Learning of Individual Survival Distributions.

Authors:  Zidi Xiu; Chenyang Tao; Ricardo Henao
Journal:  Proc ACM Conf Health Inference Learn (2020)       Date:  2020-04-02

5.  Development of novel breast cancer recurrence prediction model using support vector machine.

Authors:  Woojae Kim; Ku Sang Kim; Jeong Eon Lee; Dong-Young Noh; Sung-Won Kim; Yong Sik Jung; Man Young Park; Rae Woong Park
Journal:  J Breast Cancer       Date:  2012-06-28       Impact factor: 3.588

6.  Empirical Comparison of Continuous and Discrete-time Representations for Survival Prediction.

Authors:  Michael Sloma; Fayeq Jeelani Syed; Mohammadreza Nemati; Kevin S Xu
Journal:  Proc Mach Learn Res       Date:  2021-03

Review 7.  Recent translational research: computational studies of breast cancer.

Authors:  Michael Retsky; Romano Demicheli; William Hrushesky; John Speer; Douglas Swartzendruber; Robert Wardwell
Journal:  Breast Cancer Res       Date:  2004-12-17       Impact factor: 6.466

8.  A methodology for exploring biomarker--phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestations.

Authors:  Hongtai Huang; Andrea Fava; Tara Guhr; Raffaello Cimbro; Antony Rosen; Francesco Boin; Hugh Ellis
Journal:  BMC Bioinformatics       Date:  2015-09-15       Impact factor: 3.169

9.  Applications of machine learning in cancer prediction and prognosis.

Authors:  Joseph A Cruz; David S Wishart
Journal:  Cancer Inform       Date:  2007-02-11

10.  A novel approach for prediction of tacrolimus blood concentration in liver transplantation patients in the intensive care unit through support vector regression.

Authors:  Stijn Van Looy; Thierry Verplancke; Dominique Benoit; Eric Hoste; Georges Van Maele; Filip De Turck; Johan Decruyenaere
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.